AZD2716
Code | Size | Price |
---|
TAR-T30255-5mg | 5mg | £1,010.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T30255-50mg | 50mg | £1,982.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T30255-100mg | 100mg | £2,560.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
AZD2716 is an effective selective phospholipase A2 inhibitor for the treatment of coronary artery and cardiovascular disease.
CAS:
1845753-81-2
Formula:
C24H23NO3
Molecular Weight:
373.452
Purity:
0.98
SMILES:
C[C@H](Cc1cccc(c1)-c1cc(Cc2ccccc2)ccc1C(N)=O)C(O)=O
References
1. An Enantioselective Hydrogenation of an Alkenoic Acid as a Key Step in the Synthesis of AZD2716 Staffan Karlsson, Henrik S?rensen, S?ren M. Andersen, Angele Cruz, and Per Ryberg Org. Process Res. Dev., Articles ASAP (As Soon As Publishable) Publication Date (Web): January 7, 2016 (Article) doi: 10.1021/acs.oprd.5b00382